1.
Mikhail E., Salemi J., Mogos M., Hart S.,
Salihu H., Imudia A. National trends of adnexal surgery at the time of
hysterectomy for benign indication, United States 1998-2011. J. Minim. Invasive
Gynecol. 2015 Mar 1;22(3):S18. doi: 10.1016/j.ajog.2015.04.031
2.
Matthews KA, Gibson CJ, El Khoudary SR, et
al. Changes in cardiovascular risk factors by hysterectomy status with and
without oophorectomy: study of women’s health across the nation. J Am Coll
Cardiol 2013;62:191–200. doi:10.1016/j.jacc.2013.04.042FREE Full Text Google
Scholar
3.
James SL, Abate D, Abate KH. Global,
regional, and national incidence, prevalence, and years lived with disability
for 354 diseases and injuries for 195 countries and territories, 1990-2017: a
systematic analysis for the global burden of disease study 2017. Lancet
2018;392:1789–858. doi:10.1016/S0140-6736(18)32279-7CrossRefPubMedGoogle
Scholar
4.
Mosca, L. ∙ Benjamin, E.J. ∙ Berra, K. ...
Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in
Women—2011 Update Circulation. 2011; 123:1243-1262 Crossref Scopus (1378)
PubMed Google Scholar
5.
R. Venturella et al.3 to 5 Years later:
long-term effects of prophylactic bilateral salpingectomy on ovarian function
B.G. Kim et al. Relation of preprocedural haemoglobin level to outcomes after
percutaneous coronary intervention
6.
Aarts JWM, Nieboer TE, Johnson N, et al.
Surgical approach to hysterectomy for benign gynaecological disease. Cochrane
Database Syst Rev 2015;2015:CD003677. doi: 10.1002/14651858.CD003677.pub5Google
Scholar
7.
International Institute for Population
Sciences (IIPS) and ICF. (2021). National Family Health Survey (NFHS-5),
2019–21: India. Mumbai, India. Available at:
8.
Bhaumik, S. (2013). Oxfam calls for new
regulations to reduce unnecessary hysterectomies in private hospitals. BMJ,
346, f852.
9.
Mills, K. T., Stefanescu, A., & He, J.
(2020). The global epidemiology of hypertension. Nature Reviews Nephrology, 16,
223–237.
10.
Zhou, B., Carrillo-Larco, R. M., Danaei,
G., et al. (2021). Worldwide trends in hypertension prevalence and progress in
treatment and control from 1990 to 2019: A pooled analysis of 1201
population-representative studies with 104 million participants. The Lancet,
398, 957–980.
11.
James, S. L., Abate, D., Abate, K. H., et
al. (2018). Global, regional, and national incidence, prevalence, and years
lived with disability for 354 diseases and injuries for 195 countries and
territories, 1990–2017: A systematic analysis for the Global Burden of Disease
Study 2017. The Lancet, 392, 1789–1858.
12.
Ding, D.-C., & Sung, F.-C. (2018).
Authors’ reply re: Risk of hypertension after hysterectomy: A population-based
study. BJOG, 125, 1780.
13.
Laughlin-Tommaso, S. K., Khan, Z., Weaver,
A. L., et al. (2018). Cardiovascular and metabolic morbidity after hysterectomy
with ovarian conservation: A cohort study. Menopause, 25, 483–492.
14.
Halli, S. S., Singh, D. P., & Biradar,
R. A. (2020). Increased hypertension following hysterectomy among reproductive
women in India. American Journal of Preventive Cardiology, 4, 100131.
15.
Madika, A.-L., MacDonald, C. J., Gelot,
A., et al. (2021). Hysterectomy, non-malignant gynaecological diseases, and the
risk of incident hypertension: The E3N prospective cohort. Maturitas, 150,
22–29. https://doi.org/10.1016/j.maturitas.2021.06.001
16.
International Institute for Population
Sciences (IIPS). (2020). Longitudinal Ageing Study in India (LASI), Wave 1,
2017–18: India Report. Mumbai, India. Available at:
17.
Perianayagam, A., Bloom, D., Lee, J., et
al. (2022). Cohort profile: The longitudinal ageing study in India (LASI).
International Journal of Epidemiology, 51, e167–e176.
18.
Hammer, G. P., du Prel, J.-B., &
Blettner, M. (2009). Avoiding bias in observational studies: Part 8 in a series
of articles on evaluation of scientific publications. Deutsches Ärzteblatt
International, 106, 664–668.
19.
Hainmueller, J. (2012). Entropy balancing
for causal effects: A multivariate reweighting method to produce balanced
samples in observational studies. Political Analysis, 20, 25–46.
20.
Hainmueller, J., & Xu, Y. (2013).
Ebalance: A Stata package for entropy balancing. Journal of Statistical
Software, 54, 1–18.
21.
Luoto, R., Kaprio, J., Reunanen, A., et
al. (1995). Cardiovascular morbidity in relation to ovarian function after
hysterectomy. Obstetrics & Gynecology, 85, 515–522.
22.
Laughlin-Tommaso, S. K., Khan, Z., Weaver,
A. L., et al. (2016). Cardiovascular risk sfactors and diseases in women
undergoing hysterectomy with ovarian conservation. Menopause, 23, 121–128.
23.
Mikhail, E., Miladinovic, B., Velanovich,
V., et al. (2015). Association between obesity and the trends of routes of
hysterectomy performed for benign indications. Obstetrics & Gynaecology,
125, 912–918.
24.
Hossain, F. B., Adhikary, G., Chowdhury,
A. B., et al. (2019). Association between body mass index (BMI) and
hypertension in South Asian population: Evidence from nationally-representative
surveys. Clinical Hypertension, 25, 28.
25.
Dubey, R. K., Oparil, S., Imthurn, B., et
al. (2002). Sex hormones and hypertension. Cardiovascular Research, 53,
688–708.
26.
Lizcano, F., & Guzmán, G. (2014).
Estrogen deficiency and the origin of obesity during menopause. BioMed Research
International, 2014, 757461.
27.
Maas, A. H. E. M., & Franke, H. R.
(2009). Women’s health in menopause with a focus on hypertension. Netherlands
Heart Journal, 17, 68–72.
28.
Reckelhoff, J. F., & Fortepiani, L. A.
(2004). Novel mechanisms responsible for postmenopausal hypertension.
Hypertension, 43, 918–923.